« Startup Spartha Medical plans to launch a plant-based antiviral and antimicrobial biocidal gel in the third quarter. This solution is completely alcohol-free and is the result of research conducted by a university laboratory to protect medical implants from bacteria and … Read More
HOME
THE FIRST LINE OF VERSATILE, PERSONALISED
ANTIMICROBIAL, ANTIVIRAL
AND ANTI-INFLAMMATORY COATINGS
FOR MEDICAL DEVICES
FOR DAILY USE*
*Shown to inactivate SARS-COV2 (COVID-19)
Lire la vidéo
Hospital Acquired Infections
0
%
of the cases are related with medical devices.
SPARTHA Medical has developed multifunctional coatings that can prevent
device related infection and diminish inflammation
without affecting the function of the medical device.
We offer customised coating development for producers with specific properties optimized for the target microenvironment
We develop a « coating kit » to be utilized directly in hospitals with respect to the patient immunoprofile
We develop a biocompatible spray for general/daily use
OUR STORY
SPARTHA Medical is a spin-off from INSERM UMR1121
a public research institute with more than 20 years of experience in development of coating.
SPARTHA Medical ’s core technologies
are based patented inventions coming from two European projects (IMMODGEL and PANBioRA) that started in 2013.
OUR TEAM
Our Multidisciplinary Team brings together Know-How and Expertise in :
| Medical Device Design and Development
| Coating Technologies
| BioTechnology Business Development
| Production and Regulatory Affairs
OUR SUPPORTS
SPARTHA Medical has a strong support from :
| University of Strasbourg | SATT Conectus | INSERM and our partners in the ongoing | PANBioRa project.
We are incubated in | SEMIA and financially supported by | Grand Est region (Start-up support) and | French Public Bank of Investment (BPI, i-Lab 2019)
PLEASE DO NOT HESITATE TO CONTACT US IF YOU REQUIRE ANY FURTHER INFORMATION
TAKE A LOOK AT OUR LATEST NEWS
SPARTHA Medical continues its scientific development
In the context of the COVID19 crisis, SPARTHA Medical still collaborates with Inserm research unit 1121 and will expand the production team in order to test its new formulations Check out on LinkedIn
SPARTHA Medical finished Innouvo Program
We are very pleased to have participated in this partnership adventure between the cities of Strasbourg and Boston, which will enable us to develop our activities for the American market. This program is in addition to the two other programs … Read More